Harel Insurance Investments & Financial Services Ltd. Repligen Corp Transaction History

Harel Insurance Investments & Financial Services Ltd.

$5.8 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 26, 2021	SELL	$165.87 - $220.95 $116,109 - $154,665	-700 Closed	0 $0
Q1 2021 Apr 27, 2021	BUY	$180.37 - $226.26 $126,259 - $158,382	700 New	700 $455,000
Q4 2020 Jan 26, 2021	SELL	$148.08 - $206.57 $177,696 - $247,884	-1,200 Closed	0 $0
Q3 2020 Oct 20, 2020	BUY	$122.51 - $158.27 $147,012 - $189,924	1,200 New	1,200 $177,000

Others Institutions Holding RGEN

# of Institutions

487

Shares Held

54.4M

Call Options Held

341K

Put Options Held

235K

Black Rock Inc. New York, NY

7.57M
Shares

$944 Million
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

6.39M
Shares

$797 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

5.04M
Shares

$629 Million
0.01% of portfolio
State Street Corp Boston, MA

1.62M
Shares

$203 Million
0.01% of portfolio
Champlain Investment Partners, LLC Burlington, VT

1.42M
Shares

$177 Million
1.34% of portfolio

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Account